Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.97B |
| 2 |
Microsoft
MSFT
|
+$1.32B |
| 3 |
Amgen
AMGN
|
+$1.09B |
| 4 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$443M |
| 5 |
TSMC
TSM
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$993M |
| 2 |
CERN
Cerner Corp
CERN
|
+$863M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$586M |
| 4 |
AT&T
T
|
+$373M |
| 5 |
COHR
Coherent Inc
COHR
|
+$320M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.59% |
| 2 | Healthcare | 9.3% |
| 3 | Financials | 8.52% |
| 4 | Consumer Discretionary | 7.65% |
| 5 | Industrials | 4.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4151
First Trust Morningstar Dividend Leaders Index Fund
FDL
$7.82B
| $1.62M | ﹤0.01% |
+45,980
| New | +$1.72M |
|
|
EIGR
4152
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $1.62M | ﹤0.01% |
8,566
-437
| -5% | -$88.1K |
|
4153
Seres Therapeutics
MCRB
$48.4M
| $1.62M | ﹤0.01% |
23,577
-7,850
| -25% | -$676K |
|
|
PGTI
4154
DELISTED
PGT, Inc.
PGTI
| $1.61M | ﹤0.01% |
96,994
+621
| +0.6% | +$11.2K |
|
4155
Atea Pharmaceuticals
AVIR
$420M
| $1.61M | ﹤0.01% |
227,220
+25,527
| +13% | +$174K |
|
4156
Agilysys
AGYS
$3.06B
| $1.61M | ﹤0.01% |
34,095
+5,811
| +21% | +$226K |
|
4157
Southern Missouri Bancorp
SMBC
$850M
| $1.61M | ﹤0.01% |
35,570
+27,674
| +350% | +$1.25M |
|
4158
Stoke Therapeutics
STOK
$2.11B
| $1.61M | ﹤0.01% |
121,787
+7,745
| +7% | +$118K |
|
|
HPLT
4159
DELISTED
Home Plate Acquisition Corporation Class A Common Stock
HPLT
| $1.61M | ﹤0.01% |
164,868
-200,000
| -55% | -$1.95M |
|
|
ROVR
4160
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
| $1.6M | ﹤0.01% |
426,479
+338,269
| +383% | +$1.74M |
|
4161
PUT
Gilead Sciences
GILD
$165B
| $1.6M | ﹤0.01% |
25,900
-64,600
| -71% | -$4M |
|
4162
State Street SPDR S&P 500 Fossil Fuel Reserves Free ETF
SPYX
$2.84B
| $1.6M | ﹤0.01% |
+51,999
| New | +$1.73M |
|
|
BURU
4163
DELISTED
NUBURU INC
BURU
| $1.6M | ﹤0.01% |
804
+5
| +0.6% | +$9.9K |
|
4164
Recursion Pharmaceuticals
RXRX
$1.72B
| $1.6M | ﹤0.01% |
196,067
-13,342
| -6% | -$89.3K |
|
4165
Central Garden & Pet Co
CENT
$2.8B
| $1.59M | ﹤0.01% |
46,949
+198
| +0.4% | +$6.95K |
|
4166
PUT
Clorox
CLX
$12.7B
| $1.59M | ﹤0.01% |
+11,300
| New | +$1.61M |
|
4167
Global Industrial
GIC
$1.49B
| $1.59M | ﹤0.01% |
47,192
-8,015
| -15% | -$262K |
|
4168
NextCure
NXTC
$23.8M
| $1.59M | ﹤0.01% |
28,251
-2,840
| -9% | -$148K |
|
|
SPNS
4169
DELISTED
Sapiens International
SPNS
| $1.59M | ﹤0.01% |
65,834
-110,818
| -63% | -$2.68M |
|
|
INN
4170
Summit Hotel Properties
INN
$700M
| $1.59M | ﹤0.01% |
218,902
-25,575
| -10% | -$225K |
|
|
ZEUS
4171
DELISTED
Olympic Steel
ZEUS
| $1.59M | ﹤0.01% |
61,783
+27,773
| +82% | +$935K |
|
4172
Business First Bancshares
BFST
$1.03B
| $1.59M | ﹤0.01% |
74,482
+29,395
| +65% | +$652K |
|
4173
Rimini Street
RMNI
$471M
| $1.59M | ﹤0.01% |
264,186
-227,935
| -46% | -$1.36M |
|
|
AVLR
4174
CALL
DELISTED
Avalara, Inc.
AVLR
| $1.59M | ﹤0.01% |
22,500
| – | – |
|
|
SAFE
4175
DELISTED
Safehold Inc.
SAFE
| $1.59M | ﹤0.01% |
44,846
-10,934
| -20% | -$476K |
|
Similar funds
Goldman Sachs's Q2 2022 Portfolio in Review
As of Q2 2022, Goldman Sachs held 6,980 positions worth $400B, down 16% from $476B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Goldman Sachs's Q2 2022 filing shows 409 new, 2,564 increased, 2,532 reduced and 542 closed positions. Its largest new stake was iShares US Treasury Bond ETF: 6,205,288 shares worth $148M. The largest sale was Invesco QQQ Trust, an estimated $993M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.
- Goldman Sachs's largest Q2 2022 buy was iShares US Treasury Bond ETF: 6,205,288 shares worth $148M.
- Goldman Sachs added most to State Street SPDR S&P 500 ETF Trust in Q2 2022, an estimated $2.97B increase.
- Goldman Sachs's biggest Q2 2022 reduction was Invesco QQQ Trust, cutting an estimated $993M.
- Goldman Sachs fully exited Cerner Corp in Q2 2022, selling an estimated $863M.
- Goldman Sachs's ten largest holdings make up 18% of its $400B portfolio in Q2 2022.
- Goldman Sachs opened 409 new positions and closed 542 in Q2 2022.
- Goldman Sachs's portfolio value fell 16% quarter-over-quarter to $400B.
Based on Goldman Sachs's 13F filing for Q2 2022, filed 15 Aug 2022.